PC07.01 Debate 1: Chemotherapy Will Become a Thing of the Past in the Management of Advanced NSCLC - For

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.112
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Will Conventional Cancer Chemotherapy Soon Become Obsolete?

Journal Africain du Cancer
Oncology
2012English

When the Nose Will Become a Periscope

Journal of Health Sciences and Medicine
2019English

Will the Stroma-Derived Factor-1α (CXCL12)/CXCR4 Pathway Become a Major Concern for Advanced Colorectal Cancer?

Journal of the Korean Society of Coloproctology
2012English

Dental Therapists Make Pain a Thing of the Past for African Kids

BDJ Team
2015English

Efficacy and Safety of Iodine-125 Brachytherapy Combined With Chemotherapy in the Treatment of Advanced NSCLC in the Elderly

OncoTargets and Therapy
OncologyPharmacology
2018English

Comparison of EGFR-TKI and Chemotherapy in the First-Line Treatment of Advanced EGFR Mutation-Positive NSCLC

Neoplasma
Cancer Research
2013English

PC07.04 Debate 2: For Wild-Type NSCLC, Which Will Be the Preferred Strategy: IO Alone Versus Chemo + IO - Chemo + IO

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

194TiP: LUNAR: Phase III Study of Front-Line Chemotherapy With TTFields for Advanced Squamous NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

Best Evidence Calling for Educational Reform: Will We Do the Right Thing?

Journal of graduate medical education
Medicine
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy